Mirxes Faces Further Delay in FY2025 Results; US$14.80 Million Prepayment Review Triggers Independent Probe and Trading Suspension

Bulletin Express
04/02

Mirxes Holding Company Limited (Mirxes) announced an additional delay in releasing its FY2025 audited results after external auditor KPMG flagged issues involving 14 prepayment transactions totaling roughly US$14.80 million. Most of the transactions were executed in 2H 2025 for new projects that later stalled or failed to launch as planned.

Approximately US$9.50 million of the questioned prepayments has been returned by vendors, leaving about US$5.30 million still outstanding for completed or ongoing work. KPMG requires further independent review of these transactions before it can finalize the audit opinion.

To expedite resolution, the board unanimously established an Independent Investigation Committee (IIC) chaired by independent non-executive director Dr. Lam Sin Lai Judy and comprising Mr. Fang Xiao. The IIC has engaged Karas So LLP and Alvarez & Marsal Disputes and Investigations Limited to conduct a focused review of the 14 transactions, evaluate related internal-control compliance, and report findings directly to the board. The investigation is currently in progress.

Mirxes’ shares have been suspended from trading on the Hong Kong Stock Exchange since 9:00 a.m. on 1 April 2026 and will remain suspended until further notice. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10